MDxHealth (MDXH) Income from Non-Controlling Interests (2021 - 2023)
MDxHealth (MDXH) posted Income from Non-Controlling Interests of -$587.3 million for Q3 2022, down 381.89% sequentially from -$121.9 million in Q3 2021, and down 381.89% YoY from $208.3 million in Q3 2021.
MDxHealth (MDXH) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
MDxHealth has reported Income from Non-Controlling Interests for 2 years, with the latest figure at -$587.3 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | MDxHealth | 36.03 Mn | 15.62 Mn | 17.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -486,000.00 |
| Mar 31, 2023 | 287,000.00 |
| Sep 30, 2022 | -587.31 Mn |
| Jun 30, 2022 | 587.67 Mn |
| Mar 31, 2022 | 331,000.00 |
| Sep 30, 2021 | -121.88 Mn |